[IMCR] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[IMCR] Immunocore Holdings plc
Announcement Date
28-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -1,240.63%
YoY- -4.82%
Quarter Report
IMCR's Result
IMCR's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 75,400 70,502 105,635 62,625 60,485 55,056 48,062 35.05%
PBT -10,130 -24,079 -32,263 2,141 -17,635 -20,347 -23,074 -42.26%
Tax 1,486 357 -5,846 -175 191 292 2,129 -21.33%
NP -11,616 -24,436 -26,417 2,316 -17,826 -20,639 -25,203 -40.36%
Tax Rate - - - 8.18% - - - -
Total Cost 87,016 94,938 132,052 60,309 78,311 75,694 73,265 12.16%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -15.41 -34.66 -25.01 3.70 -29.47 -37.49 -52.44 -55.83%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.23 -0.49 -0.54 0.05 -0.37 -0.43 -0.54 -43.41%
EPS Diluted -0.23 -0.49 -0.54 0.05 -0.37 -0.43 -0.54 -43.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.